Ambulatory intravenous insulin and islet cell transplantation to treat severe type III insulin hypersensitivity in a patient with type 1 diabetes mellitus

Files

hdl_145525.pdf (236.41 KB)
  (Published version)

Date

2020

Authors

Clarke, B.
Loudovaris, T.
Radford, T.
Drogemuller, C.
Coates, P.T.
Torpy, D.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Clinical Case Reports, 2020; 8(12):2758-2761

Statement of Responsibility

Brigette Clarke, Tom Loudovaris, Toni Radford, Chris Drogemuller, Patrick Toby Coates, David Torpy

Conference Name

Abstract

Allogenic pancreatic islet cell transplantation is an appropriate treatment option to consider in the management of refractory cases of severe hypersensitivity to insulin in patients with type 1 diabetes mellitus.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

License

Grant ID

Call number

Persistent link to this record